Kerri-Ann Millar

Insider Reports History

Entity
Individual
Location
40 Guest Street, Boston, MA
Signature
/s/ Kerri-Ann Millar by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kerri-Ann Millar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 60K Jun 5, 2024 Direct

Insider Reports Filed by Kerri-Ann Millar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CUE Cue Biopharma, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Mar 6, 2024 1 $0 4 Mar 8, 2024 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Jul 21, 2023 1 $0 4 Jul 25, 2023 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Aug 21, 2022 3 -$8.63K 4 Aug 23, 2022 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Feb 9, 2022 2 $0 4 Mar 29, 2022 CHIEF FINANCIAL OFFICER
CUE Cue Biopharma, Inc. Aug 23, 2021 6 -$8.4K 4 Oct 5, 2021 CHIEF FINANCIAL OFFICER